Last Updated: November 13, 2026

YAELA Drug Patent Profile

Name: YAELA Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Yaela patents expire, and what generic alternatives are available?

Yaela is a drug marketed by Novast Labs and is included in one NDA.

The generic ingredient in YAELA is drospirenone; ethinyl estradiol. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Yaela

A generic version of YAELA was approved as drospirenone; ethinyl estradiol by DR REDDYS LABS SA on September 7^th, 2010.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for YAELA?
What are the global sales for YAELA?
What is Average Wholesale Price for YAELA?

Summary for YAELA

US Patents:	0
Applicants:	1
NDAs:	1
Patent Applications:	266
DailyMed Link:	YAELA at DailyMed

Drug patent expirations by year for YAELA

US Patents and Regulatory Information for YAELA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novast Labs	YAELA	drospirenone; ethinyl estradiol	TABLET;ORAL-28	202015-001	Nov 19, 2014	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.